Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
Bolt Biotherapeutics (BOLT)
- 4.830
- +0.050+1.05%
Close May 13 16:00 ET
- 4.830
- 0.0000.00%
Post 16:10 ET
9.28MMarket Cap-0.29P/E (TTM)
5.080High4.620Low36.21KVolume4.670Open4.780Prev Close174.49KTurnover2.04%Turnover RatioLossP/E (Static)1.92MShares9.24852wk High0.47P/B8.56MFloat Cap3.91052wk Low--Dividend TTM1.77MShs Float861.400Historical High--Div Yield TTM9.62%Range %3.910Historical Low4.819Avg Price1Lot Size
Bolt Biotherapeutics (BOLT) Income Statement
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.07%7.7M | 2.5M | 90.10%2.17M | 41.49%1.8M | -76.83%1.22M | -2.36%7.69M | 0 | -54.87%1.14M | -11.03%1.28M | 188.83%5.27M |
| Operating revenue | 0.07%7.7M | --2.5M | 90.10%2.17M | 41.49%1.8M | -76.83%1.22M | -2.36%7.69M | --0 | -54.87%1.14M | -11.03%1.28M | 188.83%5.27M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -44.25%42.33M | -48.27%8.11M | -43.86%9.87M | -45.76%11.01M | -40.37%13.34M | -9.69%75.93M | -28.30%15.67M | -15.10%17.58M | -4.51%20.31M | 10.50%22.37M |
| Selling and administrative expenses | -25.26%13.8M | -21.03%3.12M | -12.16%3.34M | -27.86%3.52M | -34.47%3.83M | -18.08%18.46M | -28.66%3.95M | -34.05%3.8M | -13.29%4.87M | 3.94%5.84M |
| -General and administrative expense | -25.26%13.8M | -21.03%3.12M | -12.16%3.34M | -27.86%3.52M | -34.47%3.83M | -18.08%18.46M | -28.66%3.95M | -34.05%3.8M | -13.29%4.87M | 3.94%5.84M |
| Research and development costs | -50.35%28.53M | -57.45%4.99M | -52.59%6.54M | -51.42%7.5M | -42.45%9.51M | -6.62%57.47M | -28.18%11.72M | -7.80%13.79M | -1.35%15.43M | 13.02%16.53M |
| Operating profit | 49.25%-34.63M | 64.23%-5.61M | 53.15%-7.7M | 51.61%-9.21M | 29.12%-12.12M | 10.45%-68.24M | 20.73%-15.67M | 9.57%-16.44M | 4.03%-19.03M | 7.18%-17.09M |
| Net non-operating interest income expense | -52.50%2.5M | -62.55%367K | -62.35%477K | -57.28%599K | -34.43%1.05M | -24.92%5.26M | -47.40%980K | -34.22%1.27M | -21.01%1.4M | 11.92%1.61M |
| Non-operating interest income | -52.50%2.5M | -62.55%367K | -62.35%477K | -57.28%599K | -34.43%1.05M | -24.92%5.26M | -47.40%980K | -34.22%1.27M | -21.01%1.4M | 11.92%1.61M |
| Other net income (expense) | -804.38%-1.24M | -11.71%-1.39M | 82K | 101.40%50K | -99.53%22K | -137K | -1.25M | -3.57M | 4.68M | |
| Special income (charges) | 69.24%-1.48M | -18.68%-1.48M | --0 | --0 | ---- | ---4.81M | ---1.25M | --0 | ---3.57M | ---- |
| -Less：Restructuring and merger&acquisition | -55.73%1.48M | 766.67%1.48M | --0 | --0 | ---- | --3.34M | ---222K | --0 | --3.57M | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --1.47M | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -94.84%241K | --87K | --82K | --50K | -99.53%22K | --4.68M | --0 | ---- | ---- | --4.68M |
| Income before tax | 47.12%-33.38M | 58.39%-6.63M | 52.93%-7.14M | 59.61%-8.56M | -2.12%-11.04M | 8.79%-63.12M | 10.99%-15.94M | 6.65%-15.18M | -17.38%-21.2M | 36.33%-10.81M |
| Income tax | ||||||||||
| Net income | 47.12%-33.38M | 58.39%-6.63M | 52.93%-7.14M | 59.61%-8.56M | -2.12%-11.04M | 8.79%-63.12M | 10.99%-15.94M | 6.65%-15.18M | -17.38%-21.2M | 36.33%-10.81M |
| Net income continuous Operations | 47.12%-33.38M | 58.39%-6.63M | 52.93%-7.14M | 59.61%-8.56M | -2.12%-11.04M | 8.79%-63.12M | 10.99%-15.94M | 6.65%-15.18M | -17.38%-21.2M | 36.33%-10.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 47.12%-33.38M | 58.39%-6.63M | 52.93%-7.14M | 59.61%-8.56M | -2.12%-11.04M | 8.79%-63.12M | 10.99%-15.94M | 6.65%-15.18M | -17.38%-21.2M | 36.33%-10.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 47.12%-33.38M | 58.39%-6.63M | 52.93%-7.14M | 59.61%-8.56M | -2.12%-11.04M | 8.79%-63.12M | 10.99%-15.94M | 6.65%-15.18M | -17.38%-21.2M | 36.33%-10.81M |
| Basic earnings per share | 46.01%-17.85 | 54.29%-3.84 | 53.09%-3.72 | 59.89%-4.46 | -3.57%-5.8 | 9.67%-33.06 | 10.64%-8.4 | 7.79%-7.93 | -15.83%-11.12 | 37.78%-5.6 |
| Diluted earnings per share | 46.01%-17.85 | 54.29%-3.84 | 53.09%-3.72 | 59.89%-4.46 | -3.57%-5.8 | 9.67%-33.06 | 10.64%-8.4 | 7.79%-7.93 | -15.83%-11.12 | 37.78%-5.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm